Insiders Flash Buy Signals Across Three Markets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Three standout insider trades filed recently show executives and major shareholders putting real money to work — and one high-profile biotech CEO cashing out at the top.
Bill Gates keeps buying Republic Services. The Microsoft co-founder filed 65 separate purchases in Republic Services, totalling over $926 million between August 10 and September 2. Gates holds the stock as a main shareholder and has been buying steadily across a wide price range (~$219–$223 per share). That kind of persistent accumulation is hard to dismiss as a passive rebalancing.
Uber's COO puts skin in the game. Andrew MacDonald, President and COO of Uber Technologies, filed on September 8 showing he bought $5.3 million worth of shares on September 4 at an average of around $75.65. These were open-market discretionary purchases — no 10b5-1 plan declared — making the signal stronger. It marks a notable vote of confidence from within the C-suite.
Evolution AB's mystery buyer goes big. Kenneth Bryan Dart, listed as the main shareholder of Swedish gaming giant Evolution AB, filed in late August disclosing purchases totalling roughly $716 million — made in July at prices around SEK 690–695 per share. The sheer size of Dart's stake-building stands out. Meanwhile, an associate at the firm was selling small clips in the same period, creating a split signal.
argenx CEO sells $21M. Tim Van Hauwermeiren, founder and CEO of argenx, filed on September 5 showing he sold $21 million in shares on September 3 at ~$908 each. The CMO and General Counsel also sold in the same window — a cluster of executive selling worth watching.
Stocks in this article
How this article was generated
- Generated
- 19 Sept 2026, 12:21
- Prompt version
- v1.0
- Data sources
- Institutional positioning
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.